BCL2L2 and heart disorder: As miR-195 reportedly negatively regulates expression of BCL-2-like protein 2 (BCL2L2), modifying the level of SNHG1 might constitute a novel strategy for treating cardiomyocyte apoptosis-related heart diseases.